Aussie Biotech, U.S. Drug Maker Sued Over Human Gene Patents
This article was originally published in PharmAsia News
Executive Summary
An Australian biotechnology company has been named in a suit filed by a cancer-advocacy group setting out on a campaign to challenge gene patents